IMMUNIC, INC. (IMUX): Nasdaq/NYSE listing notice — Immunic receives Nasdaq notice for non-compliance with $1.00 minimum bid price
IMMUNIC, INC.
On June 27, 2025, Nasdaq notified Immunic that its common stock bid price closed below $1.00 for 30 consecutive business days, violating Listing Rule 5450(a)(1).
The company has 180 calendar days (until December 24, 2025) to regain compliance by maintaining a $1.00 closing bid price for at least 10 consecutive business days.
If not compliant by the deadline, Immunic may apply for an additional 180-day period if it meets other Nasdaq Capital Market listing requirements and intends to effect a reverse stock split.
The notice has no immediate effect on listing; Immunic is evaluating options to regain compliance.
IMMUNIC, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5450(a)(1)
Exact text from the filing
June 27, 2025, Immunic, Inc. (the "Company") received a written notification (the “Notice Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that we were not in compliance with Nasdaq Listing Rule 5450(a)(1), as the closing bid price for our common stock was below the $1.00 per share requirement for the last 30 consecutive business days. The Notice Letter stated that we have 180 calendar days, or until December 24, 2025 (the “Initial Compliance Period”), to regain compliance with the minimum bid price requirement. If we do not regain compliance by the end of the Initial
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.